Legend
Please note that a short description of a certain column can be displayed when you move your mouse cursor over the column's header and hold it still. Below, a more detailed description is shown per column.
Effect: The variant's effect on the function of the gene/protein, displayed in the format 'R/C'. R is the value reported by the source (publication, submitter) and this classification may vary between records. C is the value concluded by the curator. Note that in some database the curator uses Summary records to give details on the classification of the variant.Values used: '+' indicating the variant affects function, '+?' probably affects function, '-' does not affect function, '-?' probably does not affect function, '?' effect unknown, '.' effect was not classified.
Exon: number of exon/intron containing variant; 2 = exon 2, 12i = intron 12, 2i_7i = from intron 2 to intron 7, 8i_9 = intron 8/exon 9 boundary, _1 = 5' to exon 1, 18_ = 3' of exon 18, _1_18_ = encompassing the entire 18-exon gene
DNA change (cDNA): description of variant at DNA level, based on a coding DNA reference sequence (following HGVS recommendations); e.g. c.123C>T, c.123_145del, c.123_126dup. For deletions/duplications extending beyond the reference transcript resp. {0}/{2} is used to replace del/dup. Extent of the deletion/duplication should be specified using the genomic description (g.). "-" indicates the variant described on genomic level does not affect the coding DNA reference sequence.
RNA change: description of variant at RNA level (following HGVS recommendations).
- r.123c>u
- r.? = unknown
- r.(?) = RNA not analysed but probably transcribed copy of DNA variant
- r.spl? = RNA not analysed but variant probably affects splicing
- r.(spl?) = RNA not analysed but variant may affect splicing
- r.0? = change expected to abolish transcription
Protein: description of variant at protein level (following HGVS recommendations).
- p.(Arg345Pro) = change predicted from DNA (RNA not analysed)
- p.Arg345Pro = change derived from RNA analysis
- p.? = unknown effect
- p.0? = probably no protein produced
Allele: On which allele is the variant located? Does not necessarily imply inheritance! 'Paternal' (confirmed or inferred), 'Maternal' (confirmed or inferred), 'Parent #1' or #2 for compound heterozygosity without having screened the parents, 'Unknown' for heterozygosity without having screened the parents, 'Both' for homozygozity.
Classification method: The method used for the clinical classification of this variant.
All options:
- ACMG
- ACGS
- EAHAD-CFDB
- ENIGMA
- IARC
- InSiGHT
- kConFab
- other
Clinical classification: Clinical classification of variant, preferably based on standardised criteria (e.g. ACMG), directed on the clinical consequences as published/submitted, indicated using an enriched system including inheritance: e.g. pathogenic, pathogenic (dominant), pathogenic (recessive), pathogenic (!), pathogenic (maternal), pathogenic (paternal). Standard inheritance is covered by dominant/recessive, imprinting by maternal/paternal. A '!' warns for exceptional circumstances to be explained in the 'Remarks' field (low penetrance, variants pathogenic in heterozygous state only, hypomorphic/hypermorphic variants, protective variants, etc.). Non-disease consequences (e.g. drug metabolism (pharmacogenetics), risk factor, blood group, tasting bitter) are indicated using additions to the benign classification; benign (dominant), benign (recessive), benign (!), etc. The value 'association' is used for variants associated with a phenotype and 'NA' for variants from in vitro/in silico records. NOTE: classification may differ from the opinion of the curator as given in a variant SUMMARY-record or the 'Functional effect concluded'). NOTE: pathogenic/likely pathogenic should go together with "variant (probably) affects function" In ClassFunctional.
All options:
- pathogenic
- pathogenic (dominant)
- pathogenic (recessive)
- pathogenic (!)
- pathogenic (maternal)
- pathogenic (paternal)
- likely pathogenic
- likely pathogenic (dominant)
- likely pathogenic (recessive)
- likely pathogenic (!)
- likely pathogenic (maternal)
- likely pathogenic (paternal)
- VUS
- VUS (!)
- likely benign
- likely benign (dominant)
- likely benign (recessive)
- likely benign (!)
- likely benign (maternal)
- likely benign (paternal)
- benign
- benign (dominant)
- benign (recessive)
- benign (!)
- benign (maternal)
- benign (paternal)
- conflicting
- association
- NA
DNA change (genomic) (hg19): HGVS description of variant at DNA level, based on the genomic (chromosomal) DNA reference sequence; e.g. g.12345678C>T, g.12345679del, g.12345678_12345890dup
DNA change (hg38): HGVS description of variant at DNA level, based on the hg38 genomic (chromosomal) eference sequence; e.g. g.12345678C>T, g.12345679del, g.12345678_12345890dup
Published as: listed only when different from "DNA change"; variant as reported originally (e.g. 521delT). Variants seen in animal models, tested in vitro, predicted from RNA analysis, etc. are described between brackets like c.(456C>G)
ISCN: description of the variant according to ISCN nomenclature
DB-ID: database ID of variant, grouping multiple observations of the same variant together, starting with the HGNC gene symbol, followed by an underscore (_) and a six digit number (e.g. DMD_012345). _000000 is used for variants where DNA was not analysed (change predicted from RNA analysis), variants seen in animal models or variants not seen in humans but functionally tested in vitro
Variant remarks: remarks regarding variant described, e.g. germline mosaicism in mother, 345 kb deletion, muscle RNA analysed, not in 200 control chromosomes tested, on founder haplotype, etc.
Reference: publication describing the variant submitted, incl. links to OMIM, PubMed or other source, e.g. "den Dunnen ASHG2003 P2346"
ClinVar ID: ID of variant in ClinVar database
dbSNP ID: the dbSNP ID
Origin: Origin of variant/record: Germline = in all cells, De novo = in all cells, but not in either parent, Germline/De novo (untested) = in all cells, parents not tested (use only when De novo is likely, e.g. isolated/sporadic cases with dominant disease), Somatic = present in a subset of cells, but not in either parent, Uniparental disomy = from parental disomy (maternal or paternal), CLASSIFICATION record = submitter only sharing variant classification (note another report may share Individual data), SUMMARY record = master summary record from curator (may link to another database), In vitro (cloned) = data resulting from in vitro functional assays, animal model = data from animal model, Artefact = false positive variant call, DUPLICATE record = variant already described on another chromosome (e.g. unbalanced translocation, duplicating transposition, 2nd fusion transcript, etc.)
All options:
- Germline
- De novo
- Germline/De novo (untested)
- Somatic
- Uniparental disomy
- Uniparental disomy, maternal allele
- Uniparental disomy, paternal allele
- CLASSIFICATION record
- SUMMARY record
- In vitro (cloned)
- In silico
- animal model
- Artefact
- DUPLICATE record
- Unknown
- Not applicable
Segregation: Indicates whether the variant segregates with the phenotype (yes), does not segregate with the phenotype (no) or segregation is unknown (?)
All options:
- ? = unknown
- yes = segregates with phenotype
- no = does not segregate with phenotype
- - = not applicable
Frequency: frequency in which the variant was found; e.g 5/760 chromosomes (in 5 of 760 chromosomes tested), 1/33 patients (in 1 of 33 patients analysed in study), 0.05 controls (in 5% of control cases tested)
Re-site: restriction enzyme recognition site created (+) or destroyed (-); e.g. BglII+;BamHI-
VIP: variant VIP-status was requested for matchmaking - need collaboration(s) to crack the case - please contact the submitter/curator.
NOTE: to get VIP status ask the curator.
Methylation: result of methylation test; GOM (gain of methylation), LOM (loss of methylation), 30% (30% methylated). NOTE: when several tests were done mention the method as well (e.g. MS-PCR 75%)

 Effect
|

 Exon
|

 DNA change (cDNA)
|

 RNA change
|

 Protein
|

 Classification method
|

 Clinical classification
|

 DNA change (genomic) (hg19)
|

 DNA change (hg38)
|

 Published as
|

 ISCN
|

 DB-ID
|
 Variant remarks
|

 Reference
|

 ClinVar ID
|

 dbSNP ID
|

 Origin
|

 Segregation
|

 Frequency
|

 Re-site
|

 VIP
|

 Methylation
|

 Owner
|
?/. |
_1 |
c.-85T>A |
r.(=) |
p.(=) |
- |
VUS |
g.186435247T>A |
g.186717458T>A |
- |
- |
KNG1_000002 |
- |
Journal: Loules 2020 |
ClinVar-VCV000827589.1 |
rs1579107719 |
Germline |
- |
- |
- |
- |
- |
Christian Drouet |
?/. |
1 |
c.166T>G |
r.(?) |
p.(Leu56Val) |
- |
VUS |
g.186435497T>G |
g.186717708T>G |
- |
- |
KNG1_000019 |
Introduced in ClinVar as VUS by Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein |
- |
ClinVar-SCV003807556.1 |
- |
Germline |
- |
- |
- |
- |
- |
Christian Drouet |
+/. |
2i |
c.306+2T>A |
r.spl |
p.? |
- |
pathogenic (recessive) |
g.186438006T>A |
g.186720217T>A |
c.[306+2T>A];[306+2T>A] |
- |
KNG1_000009 |
His daughter and his son display a normal aPTT.
Laboratory analyses show normal or increased levels of the intrinsic pathway factors, and decreased PK and HK.
Introduced in ClinVar as pathogenic by Institute for Clinical Chemistry and Laboratory Medicine, University Medical Center Mainz, Germany |
Journal: Adenaeuer 2023 |
ClinVar-SCV004031439.1 |
- |
Germline |
- |
- |
- |
- |
- |
Christian Drouet |
?/. |
4 |
c.421G>A |
r.(?) |
p.(Asp141Asn) |
- |
VUS |
g.186442906G>A |
g.186725117G>A |
- |
- |
KNG1_000003 |
- |
Journal: Loules 2020 |
ClinVar-VCV000827590.1 |
rs1579116763 |
Germline |
- |
0.0 (0/10680; ALFA Project) |
- |
- |
- |
Christian Drouet |
+/. |
4 |
c.460C>A |
r.(?) |
p.(Pro154Thr) |
- |
pathogenic (recessive) |
g.186442945C>A |
g.186725156C>A |
- |
- |
KNG1_000023 |
- |
Journal: Chen 2024 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Christian Drouet |
+/. |
4 |
c.488del |
r.(?) |
p.(Gly163Alafs*20) |
- |
pathogenic |
g.186442973del |
g.186725184del |
c.[488del];[1165C>T] |
- |
KNG1_000012 |
Compound c.[488del];[1165C>T] variants abolish expression of HK and LK and function of HK |
Journal: Jeung 2020 Journal: Adenaeuer 2022 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Christian Drouet |
+/. |
4 |
c.523_524dup |
r.(?) |
p.(Leu176Profs*8) |
- |
pathogenic |
g.186443008_186443009dup |
g.186725219_186725220dup |
c.[523_524dup];[523_524dup] |
- |
KNG1_000013 |
Proband homozygous carrier of c.[523_524dup];[523_524dup] variants does not express both HK and LK proteins
HK activity is also reduced in the plasma of proband's three heterozygous children |
Journal: Fukushima 2014 Journal: Adenaeuer 2022 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Christian Drouet |
+/. |
5 |
c.586C>T |
r.(?) |
p.(Arg196*) |
- |
pathogenic (recessive) |
g.186445047C>T |
g.186727258C>T |
c.[c.586C>T];[c.586C>T] |
- |
KNG1_000010 |
Proband sample displays normal levels of intrinsic coagulation factors, except for a slightly decreased FXI:C and PK:C, and a strongly decreased HK:C, indicating total HK deficiency.
c.586C>T variant affects HK and LK expression. |
Journal: Hayashi 1990 Journal: Adenaeuer 2022 |
ClinVar-VCV000000572.1 |
rs121918131 |
Germline |
- |
0.00001061 (gnomAD) |
- |
- |
- |
Christian Drouet |
+/. |
5 |
c.586C>T |
r.(?) |
p.(Arg196*) |
- |
pathogenic (recessive) |
g.186445047C>T |
g.186727258C>T |
c.[c.586C>T];[c.586C>T] |
- |
KNG1_000010 |
Intrinsic coagulation factors were within the reference range except for a borderline decreased FXI:C and PK:C, and a strongly decreased HK:C, indicating total HK deficiency.
c.586C>T variant affects HK and LK expression.
Considered pathogenic by Institute for Clinical Chemistry and Laboratory Medicine, University Medical Center Mainz, Germany |
Journal: Nazir 2019 Journal: Adenaeuer 2022 |
ClinVar-VCV000000572.1 |
rs121918131 |
Germline |
- |
0.00001061 (gnomAD) |
- |
- |
- |
Christian Drouet |
+/. |
5 |
c.586C>T |
r.(?) |
p.(Arg196*) |
- |
pathogenic |
g.186445047C>T |
g.186727258C>T |
c.[586C>T];[586C>T] |
- |
KNG1_000010 |
Proband plasma presenting with a complete deficit of HK and LK |
PubMed: Ishimaru 1999 Journal: Adenaeuer 2022 |
ClinVar-VCV000000572.1 |
rs121918131 |
Germline |
- |
0.00001061 (gnomAD) |
- |
- |
- |
Christian Drouet |
-/. |
5 |
c.587G>A |
r.(?) |
p.(Arg196Gln) |
- |
likely benign (!) |
g.186445048G>A |
g.186727259G>A |
- |
- |
KNG1_000008 |
p.(Arg196Gln) variant in the cystatin kininogen-type 2 (151-254)
Introduced as likely benign with the following ACMG criteria PM1, PM1, BP1, BP2 |
- |
- |
rs144123648 |
Unknown |
- |
0.0004597 |
- |
- |
- |
Christian Drouet |
-?/. |
- |
c.587G>A |
r.(?) |
p.(Arg196Gln) |
- |
likely benign |
g.186445048G>A |
- |
KNG1(NM_001102416.3):c.587G>A (p.R196Q) |
- |
KNG1_000008 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Utrecht |
+/. |
5 |
c.618T>G |
r.(?) |
p.(Cys206Trp) |
ACMG |
likely pathogenic |
g.186445079T>G |
g.186727290T>G |
c.[618T>G](;)[1165C>T] |
- |
KNG1_000024 |
Compound heterozygous female carrier both c.618T>G and c.1165C>T.
c.618T>G variant disrupts the disulfide bond between Cys206 and Cys218; c.1165C>T is a non-sense variant with truncation of the D5 domain of the protein. |
Journal: Lv 2025 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Christian Drouet |
+?/. |
5 |
c.654C>A |
r.(?) |
p.(Cys218*) |
- |
VUS (!) |
g.186445115C>A |
g.186727326C>A |
- |
- |
KNG1_000020 |
Variant provisionally introduced; position must be confirmed by authors.
Variant provisionally introduced as VUS pending a demonstration as causative for HAE-nC1-INH |
Journal: Dias de Castro 2024 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Christian Drouet |
+/. |
6 |
c.718C>T |
r.(?) |
p.(Arg240*) |
- |
pathogenic (recessive) |
g.186449379C>T |
g.186731590C>T |
c.[718C>T];[1038+1G>A] |
- |
KNG1_000011 |
A German kindred with a female symptomatic carrier of compound variants c.[718C>T];[1038+1G>A], with abolished expression of HK and LK, and her asymptomatic heterozygous parents |
Journal: Adenaeuer 2022 |
ClinVar-SCV004031437.1 |
rs761496908 |
Germline |
- |
0.000006206 |
- |
- |
- |
Christian Drouet |
+?/. |
8i |
c.1038+1G>A |
r.spl |
p.? |
- |
pathogenic (recessive) |
g.186456996G>A |
g.186739207G>A |
c.[1038+1G>A](;)[1165C>T] |
- |
KNG1_000007 |
compound variants c.[1038+1G>A](;)[1165C>T] abolished expression of both HK and LK
The female compound heterozygous proband has been originally described as being prekallikrein (PK) deficient due to low PK activity (7%)
Variant c.1038+1G>A introduced in ClinVar as pathogenic by Institute for Clinical Chemistry and Laboratory Medicine, University Medical Center Mainz, Germany |
PubMed: Barco 2020, Journal: Barco 2020 Journal: Adenaeuer 2022 |
ClinVar-SCV004031440.1 |
rs377594184 |
Germline |
- |
0.000009311 |
- |
- |
- |
Christian Drouet |
+/. |
8i |
c.1038+1G>A |
r.spl |
p.? |
- |
pathogenic (recessive) |
g.186456996G>A |
g.186739207G>A |
c.[718C>T];[1038+1G>A] |
- |
KNG1_000007 |
A German kindred with a female symptomatic carrier of compound variants c.[718C>T];[1038+1G>A], with abolished expression of HK and LK, and her asymptomatic parents |
Journal: Adenaeuer 2022 |
ClinVar-SCV004031440.1 |
rs377594184 |
Germline |
- |
0.000009311 |
- |
- |
- |
Christian Drouet |
+?/. |
10 |
c.1136T>A |
r.(?) |
p.(Met379Lys) |
ACMG |
pathogenic |
g.186459321T>A |
g.186741532T>A |
- |
- |
KNG1_000004 |
c.1136T>A introduced as Class 4 variant (ACMG classification).
p.(Met379Lys) variant changes the N-terminal cleavage site of bradykinin from HK and Lys-bradykinin from LK. This might lead to a functionally active but abnormal bradykinin or Lys-bradykinin in HAE-KNG1, with putative change of the inactivation process by enzymes, e.g. aminopeptidase P, angiotensin-I converting enzyme, and others, possibly resulting in a prolonged half-life time and a higher than normal activity of this mutant peptide ligand.
It has been demonstrated that the Met379Lys substitution increases HK and LK susceptibility to cleavage by plasmin, resulting in release of Lys-bradykinin (kallidin). This is the second example of a mutation that could cause HAE independently of plasma kallikrein, and the first described that involves Lys-bradykinin production.
Introduced as pathogenic in ClinVar by OMIM; angioedema, hereditary, 6; HAE6 |
PubMed: Bork 2019 Journal: Bork 2019 Journal: Dickeson 2023 |
ClinVar-SCV001712268.1 |
rs752411996 |
Germline |
yes |
6.860E-7 |
- |
- |
- |
Christian Drouet |
+/. |
10 |
c.1136T>A |
r.(?) |
p.(Met379Lys) |
ACMG |
pathogenic |
g.186459321T>A |
g.186741532T>A |
- |
- |
KNG1_000004 |
This variant (class 4 ACMG) changes the N-terminal cleavage site of bradykinin from both high molecular weight (HMWK) and low molecular weight (LMWK) kininogens.The patient's kininogen immunoblot shows a majority of uncleaved kininogen, with a molecular weight of 120 KDa, and a minority of cleaved kininogen at 45 KDa.
Introduced in ClinVar as a pathogenic variant by OMIM; ascribed to hereditary angioedema type 6, HAE6 |
Journal: Hardy 2023 |
ClinVar-SCV001712268 |
rs752411996 |
Germline |
yes |
6.860E-7 |
- |
- |
- |
Christian Drouet |
+?/. |
10 |
c.1165C>T |
r.(?) |
p.(Arg389*) |
- |
pathogenic (recessive) |
g.186459350C>T |
g.186741561C>T |
c.[1038+1G>A];[1165C>T] |
- |
KNG1_000006 |
compound variant c.[1038+1G>A](;)[1165C>T]
c.1165C>T has been introduced as pathogenic in ClinVar by University Medical Center Mainz Germany |
PubMed: Barco 2020, Journal: Barco 2020 Journal: Adenaeuer 2022 |
ClinVar-VCV001803726.1 |
rs752411996 |
Germline |
- |
0.000006211 |
- |
- |
- |
Christian Drouet |
+/. |
10 |
c.1165C>T |
r.(?) |
p.(Arg389*) |
- |
pathogenic (recessive) |
g.186459350C>T |
g.186741561C>T |
c.[488delG];[1165C>T] |
- |
KNG1_000006 |
Compound c.[488delG];[1165C>T] variants abolish expression of Hk and LK and function of HK
c.1165C>T has been introduced as pathogenic in ClinVar by University Medical Center Mainz Germany |
Journal: Jeung 2020 Journal: Adenaeuer 2022 |
ClinVar-VCV001803726.1 |
rs752411996 |
Germline |
- |
0.000006211 |
- |
- |
- |
Christian Drouet |
+/. |
10 |
c.1165C>T |
r.(?) |
p.(Arg389*) |
ACMG |
pathogenic (recessive) |
g.186459350C>T |
g.186741561C>T |
c.[618T>G](;)[1165C>T] |
- |
KNG1_000006 |
Compound heterozygous female carrier both c.618T>G and c.1165C>T.
c.618T>G variant disrupts the disulfide bond between Cys206 and Cys218; c.1165C>T is a non-sense variant with truncation of the D5 domain of the protein. |
Journal: Lv 2025 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Christian Drouet |
+/. |
10 |
c.1216dup |
r.(?) |
p.(His406Profs*10) |
- |
pathogenic (recessive) |
g.186459401dup |
g.186741612dup |
c.[1216dup];[1216dup] |
- |
KNG1_000014 |
A family with 1 homozygous symptomatic proband and 5 heterozygous asymptomatic carriers |
Journal: Shigekiyo 2007 Journal: Adenaeuer 2022 |
ClinVar-VCV000000575.1 |
rs797044430 |
Germline |
- |
- |
- |
- |
- |
Christian Drouet |
-?/. |
- |
c.1311A>C |
r.(?) |
p.(Arg437Ser) |
- |
likely benign |
g.186459496A>C |
- |
KNG1(NM_001102416.3):c.1311A>C (p.R437S) |
- |
KNG1_000017 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Utrecht |
+/. |
10 |
c.1404G>C |
r.(1404G>C) |
p.(Gln468His) |
ACMG |
pathogenic |
g.186459589G>C |
g.186741800G>C |
- |
- |
KNG1_000026 |
- |
Journal: Chen 2025 |
- |
- |
Germline/De novo (untested) |
yes |
- |
- |
- |
- |
Christian Drouet |
+/. |
10 |
c.1456C>T |
r.(?) |
p.(Gln486*) |
- |
pathogenic (recessive) |
g.186459641C>T |
g.186741852C>T |
c.[1456C>T];[1456C>T] |
- |
KNG1_000015 |
Male homozygous proband and his two homozygous sisters are presenting with a prolonged aPTT and a decreased HK expression |
Journal: Yang 2020 Journal: Adenaeuer 2022 |
- |
- |
Germline |
yes |
- |
- |
- |
- |
Christian Drouet |
+/. |
10 |
c.1493del |
r.(?) |
p.(Lys498Serfs*54) |
- |
pathogenic |
g.186459678del |
g.186741889del |
c.[1493del];[1493del] |
- |
KNG1_000016 |
Homozygous c.[1493del];[1493del] variants abolish HK expression. The KNG1 gene was present in the proband to direct the expression of LK of apparent normal size.
Heterozygous carriers exhibit reduced antigenic HK.
Truncation or frameshift at or before position 480 of the mature HK prevents biosynthesis, processing, and/or HK secretion |
Journal: Krijanovski 2003 Journal: Adenaeuer 2022 |
ClinVar-VCV000000573.1 |
rs797044429 |
Germline |
- |
- |
- |
- |
- |
Christian Drouet |
?/. |
- |
c.1609_1610del |
r.(?) |
p.(Gln537Aspfs*25) |
- |
VUS |
g.186459794_186459795del |
- |
KNG1(NM_001102416.3):c.1609_1610del (p.(Gln537Aspfs*25)) |
- |
KNG1_000025 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Leiden |
-?/. |
- |
c.1643T>C |
r.(?) |
p.(Ile548Thr) |
- |
likely benign |
g.186459828T>C |
- |
KNG1(NM_001102416.2):c.1643T>C (p.(Ile548Thr)), KNG1(NM_001102416.3):c.1643T>C (p.I548T) |
- |
KNG1_000018 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Utrecht |
?/. |
- |
c.1643T>C |
r.(?) |
p.(Ile548Thr) |
- |
VUS |
g.186459828T>C |
- |
KNG1(NM_001102416.2):c.1643T>C (p.(Ile548Thr)), KNG1(NM_001102416.3):c.1643T>C (p.I548T) |
- |
KNG1_000018 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Leiden |
+/. |
10 |
c.1720C>G |
r.(?) |
p.(Pro574Ala) |
ACMG |
pathogenic (recessive) |
g.186459905C>G |
g.186742116C>G |
- |
- |
KNG1_000005 |
Incomplete penetrance: 1 family, 2 patients had recurrent attacks, also heterozygous for a ACE gene c.1459C>T;p.(Arg487Cys) variant, a third patient, had only one attack during his lifetime and did not carry the ACE variant.
Introduced as pathogenic in ClinVar; Angioedema, Hereditary, 6; HAE6 |
PubMed: Loules 2020 Journal: Loules 2020 |
ClinVar-SCV001712269.1 |
rs1369253342 |
Germline |
yes |
0.000003181 |
- |
- |
- |
Christian Drouet |
+?/. |
17 |
c.1742T>C |
r.(?) |
p.(Ile581Thr) |
- |
association |
g.186459927T>C |
g.186742138T>C |
- |
- |
KNG1_000021 |
SNP associated with with a shortening of the activated partial thromboplastin time and increased susceptibility to venous thrombosis |
Journal: Houlihan 2010 Journal: Morange 2011 Journal: Li 2023 |
- |
rs710446 |
Germline |
- |
0.416246 |
- |
- |
- |
Christian Drouet |
?/. |
- |
c.1744C>T |
r.(?) |
p.(Gln582*) |
- |
VUS |
g.186459929C>T |
- |
KNG1(NM_001102416.3):c.1744C>T (p.Q582*) |
- |
KNG1_000022 |
VKGL data sharing initiative Nederland |
- |
- |
- |
CLASSIFICATION record |
- |
- |
- |
- |
- |
VKGL-NL_Groningen |
./. |
- |
c.*1404C>T |
r.(=) |
p.(=) |
- |
pathogenic |
g.186461524C>T |
g.186743735C>T |
- |
- |
KNG1_000001 |
association variant/phenotype uncertain |
PubMed: DDDS 2015, Journal: DDDS 2015 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
./. |
- |
c.*1404C>T |
r.(=) |
p.(=) |
- |
pathogenic |
g.186461524C>T |
g.186743735C>T |
- |
- |
KNG1_000001 |
association variant/phenotype uncertain |
PubMed: DDDS 2015, Journal: DDDS 2015 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
./. |
- |
c.*1404C>T |
r.(=) |
p.(=) |
- |
pathogenic |
g.186461524C>T |
g.186743735C>T |
- |
- |
KNG1_000001 |
association variant/phenotype uncertain |
PubMed: DDDS 2015, Journal: DDDS 2015 |
- |
- |
Germline |
- |
- |
- |
- |
- |
Johan den Dunnen |
-?/. |
- |
c.*1404C>T |
r.(?) |
p.(=) |
- |
benign |
g.186461524C>T |
g.186743735C>T |
NM_000893.4:c.1234C>T |
- |
KNG1_000001 |
The stop variant c.*1404C>T identified by Mathey 2022 is located in exon 11, and downstream of both the bradykinin sequence and its cleavage sites.
Exon 11 of KNG1 encodes the unique light chain of LK, whose exact function has yet to be determined.
The consequences of the stop variant p.(Arg412Ter) are unclear.
Additionally, the variant c.*1404C>T has been shown as a risk allele that increases the stability of KNG1 mRNA, leading to increased susceptibility to HBV infection.
Considered benign by Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine, Cambridge MA |
Journal: Mathey 2022 Journal: Zhang 2023 |
ClinVar-VCV000403021.3 |
rs76438938 |
Germline |
- |
0.03019 (gnomAD) |
- |
- |
- |
Christian Drouet |